MedTrace Logo

Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer

NCT02363049 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 278

Last updated 2017-02-23

No results posted yet for this study

Summary

The present study is a multicentric randomized phase III trial designed to assess whether overall survival and quality of life are improved in patients with asymptomatic colon cancer and unresectable SLM treated with resection of the PT followed by chemotherapy versus chemotherapy alone.

Conditions

  • Malignant Neoplasm of Large Intestine
  • Colon Cancer Liver Metastasis

Interventions

PROCEDURE

Colectomy

DRUG

Chemotherapy

Sponsors & Collaborators

  • UNICANCER

    collaborator OTHER

  • Federation Francophone de Cancerologie Digestive

    collaborator OTHER

  • GERCOR - Multidisciplinary Oncology Cooperative Group

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Mehdi Karoui, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02363049 on ClinicalTrials.gov